| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,278 |
10,062 |
$829K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,996 |
5,824 |
$701K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,493 |
3,370 |
$508K |
| 87428 |
|
5,044 |
4,972 |
$123K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,447 |
2,351 |
$49K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
290 |
281 |
$42K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
592 |
571 |
$29K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,866 |
1,781 |
$25K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,365 |
6,060 |
$24K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
463 |
453 |
$19K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
573 |
549 |
$15K |
| 82550 |
|
3,057 |
2,946 |
$14K |
| 80051 |
|
3,031 |
2,926 |
$14K |
| 80053 |
Comprehensive metabolic panel |
1,849 |
1,753 |
$13K |
| 71046 |
Radiologic examination, chest; 2 views |
1,175 |
1,146 |
$13K |
| 82565 |
|
3,029 |
2,926 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,463 |
1,319 |
$11K |
| 84520 |
|
3,018 |
2,915 |
$11K |
| 81003 |
|
4,368 |
4,237 |
$9K |
| 82947 |
|
3,274 |
3,083 |
$8K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
602 |
580 |
$8K |
| 70450 |
Computed tomography, head or brain; without contrast material |
166 |
161 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,474 |
1,447 |
$8K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
845 |
799 |
$7K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
94 |
89 |
$7K |
| 84484 |
|
922 |
806 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
299 |
289 |
$6K |
| 81025 |
|
2,024 |
1,967 |
$5K |
| 82977 |
|
778 |
762 |
$5K |
| 71045 |
Radiologic examination, chest; single view |
835 |
801 |
$5K |
| 84460 |
|
794 |
778 |
$4K |
| 84450 |
|
794 |
778 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
504 |
443 |
$4K |
| 82247 |
|
787 |
771 |
$4K |
| 84075 |
|
787 |
771 |
$3K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
16 |
16 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
227 |
204 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
172 |
163 |
$3K |
| 83605 |
|
503 |
469 |
$3K |
| 82150 |
|
799 |
783 |
$3K |
| 84155 |
|
787 |
771 |
$2K |
| 85379 |
|
326 |
315 |
$2K |
| 73610 |
|
159 |
150 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
814 |
752 |
$2K |
| 82040 |
|
787 |
771 |
$2K |
| 73630 |
|
142 |
133 |
$1K |
| 83880 |
|
44 |
43 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
166 |
76 |
$908.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
13 |
12 |
$798.72 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
103 |
102 |
$604.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
38 |
38 |
$585.16 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
27 |
26 |
$579.52 |
| 87040 |
|
46 |
27 |
$504.00 |
| 87420 |
|
103 |
103 |
$483.24 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
25 |
25 |
$382.64 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
25 |
25 |
$382.64 |
| 73502 |
|
13 |
13 |
$326.78 |
| 73562 |
|
18 |
14 |
$289.09 |
| 73110 |
|
37 |
35 |
$281.75 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
14 |
13 |
$258.09 |
| 73130 |
|
28 |
25 |
$253.00 |
| 96376 |
|
113 |
104 |
$108.00 |
| 87077 |
|
17 |
14 |
$85.20 |
| 80305 |
|
14 |
14 |
$71.82 |
| 90715 |
|
83 |
79 |
$0.00 |